Literature DB >> 15144500

The influence of antisense oligonucleotides against STAT5 on the regulation of normal haematopoiesis in a bone marrow model.

M Baśkiewicz-Masiuk1, M Paczkowski, B Machaliński.   

Abstract

Cytokines and growth factors that take part in the regulation of haematopoietic cell development activate many signalling pathways in target cells. The STAT5 (signal transducers and activators of transcription) proteins are members of a family of signal transducers and activators of transcription that can be activated after cytokine stimulation. Their binding to promoters of different genes influences cell proliferation, differentiation and survival. It is suggested that they play an important role in haematopoiesis, however, the question of the real function of STAT5 proteins requires further examination. The aim of our study was to investigate the role of STAT5 in the proliferation and apoptosis of normal haematopoietic bone marrow cells derived from heparinized cadaveric organ donors (HCOD). We applied antisense oligodeoxynucleotides (ODNs) to block STAT5A and STAT5B at the mRNA level and the reverse transcription polymerase chain reaction method to study STAT5 mRNA expression in the cells after incubation with ODNs. Moreover, we performed Western blot analysis of the STAT5A protein after exposure to antisense STAT5A. We analysed the clonogenicity of the colony-forming unit of granulocytes-macrophages and the burst-forming unit of erythrocytes in methylcellulose cultures according to the type and the dose of ODNs. We also examined apoptosis induced in bone marrow mononuclear and CD34(+) cells by employing annexin V staining and the TUNEL method using flow cytometry (FACScan). We found that the perturbation of STAT5 expression decreased the clonogenicity of bone marrow haematopoietic cells. However, we did not observe any significant increase in the percentage of apoptotic cells after incubation with antisense ODNs. It was concluded that the STAT5 proteins play a significant role in the proliferation of human bone marrow cells harvested from HCOD. These proteins might be critical in the regulation of haematopoiesis, especially under stress conditions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15144500      PMCID: PMC6495452          DOI: 10.1111/j.1365-2184.2004.00308.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  37 in total

1.  Heparinized cadaveric organ donors (HCOD)--a potential source of hematopoietic cells for transplantation and gene therapy.

Authors:  B Machalinski; J Kijowski; W Marlicz; A Gontarewicz; M Markiewski; M Paczkowski; A Kopkowski; M Majka; M Ostrowski; M Z Ratajczak
Journal:  Transplantation       Date:  2001-04-15       Impact factor: 4.939

2.  Morphological analysis of the bone marrow biopsies derived from heparinized cadaveric organ donors before and after disconnecting from the respirator.

Authors:  B Machaliński; A Gontarewicz; M Z Ratajczak
Journal:  Ann Transplant       Date:  2001       Impact factor: 1.530

3.  Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation.

Authors:  M Kieslinger; I Woldman; R Moriggl; J Hofmann; J C Marine; J N Ihle; H Beug; T Decker
Journal:  Genes Dev       Date:  2000-01-15       Impact factor: 11.361

4.  STAT5 promotes multilineage hematolymphoid development in vivo through effects on early hematopoietic progenitor cells.

Authors:  Jonathan W Snow; Ninan Abraham; Melissa C Ma; Nancy W Abbey; Brian Herndier; Mark A Goldsmith
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

Review 5.  Nucleic acid therapeutics: state of the art and future prospects.

Authors:  A M Gewirtz; D L Sokol; M Z Ratajczak
Journal:  Blood       Date:  1998-08-01       Impact factor: 22.113

Review 6.  Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation.

Authors:  P M Grimley; F Dong; H Rui
Journal:  Cytokine Growth Factor Rev       Date:  1999-06       Impact factor: 7.638

7.  Dominant negative mutants implicate STAT5 in myeloid cell proliferation and neutrophil differentiation.

Authors:  R L Ilaria; R G Hawley; R A Van Etten
Journal:  Blood       Date:  1999-06-15       Impact factor: 22.113

8.  Reduced lymphomyeloid repopulating activity from adult bone marrow and fetal liver of mice lacking expression of STAT5.

Authors:  Kevin D Bunting; Heath L Bradley; Teresa S Hawley; Richard Moriggl; Brian P Sorrentino; James N Ihle
Journal:  Blood       Date:  2002-01-15       Impact factor: 22.113

9.  Oligodeoxynucleotide-mediated inhibition of c-myb gene expression in autografted bone marrow: a pilot study.

Authors:  Selina M Luger; Stephen G O'Brien; Janina Ratajczak; Mariusz Z Ratajczak; Rosemarie Mick; Edward A Stadtmauer; Peter C Nowell; John M Goldman; Alan M Gewirtz
Journal:  Blood       Date:  2002-02-15       Impact factor: 22.113

10.  Cell intrinsic defects in cytokine responsiveness of STAT5-deficient hematopoietic stem cells.

Authors:  Heath L Bradley; Teresa S Hawley; Kevin D Bunting
Journal:  Blood       Date:  2002-07-25       Impact factor: 22.113

View more
  1 in total

1.  Human and simian immunodeficiency viruses deregulate early hematopoiesis through a Nef/PPARgamma/STAT5 signaling pathway in macaques.

Authors:  Stéphane Prost; Mikael Le Dantec; Sylvie Augé; Roger Le Grand; Sonia Derdouch; Gwenaelle Auregan; Nicole Déglon; Francis Relouzat; Anne-Marie Aubertin; Bernard Maillere; Isabelle Dusanter-Fourt; Marek Kirszenbaum
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.